SEC Form 4 · accession 0001127602-17-027110

GILEAD SCIENCES, INC. · GILD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive Chairman · Director

Period of report

Aug 31, 2017

Accepted (ET)

Sep 6, 2017 · 8:23 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000882095

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Aug 31, 2017	G	129,870	$0.00	D	2,996,766	D
Common Stock	Sep 1, 2017	M	73,333	$21.575	A	3,070,099	D
Common Stock^F4	Sep 1, 2017	S	58,338	$83.0316	D	3,011,761	D
Common Stock^F5	Sep 1, 2017	S	14,995	$83.4341	D	2,996,766	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-qualified Stock Option (Right to Buy)^F3	$21.575	Sep 1, 2017	M	73,333	D	—	Jan 30, 2018	Common Stock	73,333	219,999	D

F1Shares gifted to charitable trust
F2The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F3The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F4Sale prices reported for the transactions reported here range from $82.29 to $83.29. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5Sale prices reported for the transactions reported here range from $83.30 to $84.06. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.